RESUMEN
【Objective】 To retrospectively analyse the quality status and annual trend of centralized blood screening across the regions of Hubei province, and discuss the effect and advantages of the application of centralized blood screening across blood establishment. 【Methods】 Blood screening results of five blood establishment across Hubei province from 2005 to 2019 were statistically analyzed. The sample size, overall rate of qualified blood donations, overall and annual rate of positive testing items were compared among regions. 【Results】 There were differences in blood quality among different regions of Hubei province. In Wuhan, Ezhou, Xiantao, Tianmen and Qianjiang, the overall rate of qualified blood donations was 97.1%(2 466 396/2 538 871), 96.5%(85 405/88 547), 95.2%(59 087/62 047), 95.5%(68 920/72 146) and 94.7%(34 274/36 188), respectively; the overall deferral rate of ALT was 1.472% (37 374/2 538 871), 2.024% (1 792/88 547), 2.840% (1 762/62 047), 2.476% (1 786/72 146) and 3.777% (1 367/36 188), with significant differences across regions; the overall positive rate of HBsAg was 0.587% (14 897/2 538 871), 0.664% (588/88 547), 1.094% (679/62 047), 1.282% (925/72 146) and 0.862% (312/36 188), with significant differences across regions. The deferral rate of ALT showed a downward trend by year in these five regions from 2005 to 2019.An decreasing trend in the seroprevalence of HBV was noticed in Wuhan, Tianmen, and Qianjiang, HCV in Wuhan, Ezhou, and Tianmen, as well as syphilis infections in Wuhan. 【Conclusion】 Centralized blood screening can optimize the allocation of testing resources, reveal problems during blood collection and supply and improve the ability to guarantee blood safety. Future efforts are needed to expand the scope of centralized blood screening and seek for a centralized screening mode suitable for local situation.
RESUMEN
ObjectivesThe prevalence of antibodies to SARS-CoV-2 among blood donors in China remains unknown. To reveal the missing information, we investigated the seroprevalence of SARS-CoV-2 antibodies among blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang of China. DesignCross-sectional study SettingThree blood centers, located in the central, south and north China, respectively, recruiting from January to April 2020. Participants38,144 healthy blood donors donated in Wuhan, Shenzhen and Shijiazhuang were enrolled, who were all met the criteria for blood donation during the COVID-19 pandemic in China. Main outcome measuresSpecific antibodies against SARS-CoV-2 including total antibody (TAb), IgG antibody against receptor-binding domain of spike protein (IgG-RBD) and nucleoprotein (IgG-N), and IgM. Pseudotype lentivirus-based neutralization test was performed on all TAb-positive samples. In addition, anonymous personal demographic information, including gender, age, ethnicity, occupation and educational level, and blood type were collected. ResultsA total of 519 samples from 410 donors were confirmed by neutralization tests. The SARS-CoV-2 seroprevalence among blood donors was 2.29% (407/17,794, 95%CI: 2.08% to 2.52%) in Wuhan, 0.029% (2/6,810, 95%CI: 0.0081% to 0.11%) in Shenzhen, and 0.0074% (1/13,540, 95%CI: 0.0013% to 0.042%) in Shijiazhuang, respectively. The earliest emergence of SARS-CoV-2 seropositivity in blood donors was identified on January 20, 2020 in Wuhan. The weekly prevalence of SARS-CoV-2 antibodies in Wuhans blood donors changed dynamically and were 0.08% (95%CI: 0.02% to 0.28%) during January 15 to 22 (before city lockdown), 3.08% (95%CI: 2.67% to 3.55%) during January 23 to April 7 (city quarantine period) and 2.33% (95%CI: 2.06% to 2.63%) during April 8 to 30 (after lockdown easing). Female and older-age were identified to be independent risk factors for SARS-CoV-2 seropositivity among donors in Wuhan. ConclusionsThe prevalence of antibodies to SARS-CoV-2 among blood donors in China was low, even in Wuhan city. According to our data, the earliest emergence of SARS-CoV-2 in Wuhans donors should not earlier than January, 2020. As most of the population of China remained uninfected during the early wave of COVID-19 pandemic, effective public health measures are still certainly required to block viral spread before a vaccine is widely available.
RESUMEN
OBJECTIVE: To establish a simultaneously detecting method for 9 kinds of anion in workplace air by ion chromatography. METHODS: Nine kinds of anions in workplace air include fluoride ion,chloride ion,nitrite ion,bromide ion,nitrate ion,sulfate ion,phosphate ion,oxalate denominationbl and iodide ion were sampled with sodium carbonatesodium bicarbonate( concentration 3. 2,1. 1 mmol/L respectively),separated by the anion column,detected by the conductivity detector and quantified by external standard method. RESULTS: The linearity of the 9 anions in the corresponding mass concentration range was good( correlation coefficient > 0. 999). The detection limit was 0. 02-0. 18mg/L and the marking recovery was 96. 0%-100. 5%. The within-run relative standard deviation( RSD) was 0. 3%-2. 5%,and the between-run RSD was 0. 4%-3. 1%. All the sampling efficiencies were > 96. 8%,and the samples could be stored at room temperature for 5 days. CONCLUSION: The method has good accuracy,high sensitivity,with simple and rapid operation,and can simultaneously measure various anions in the air of workplace.